🔎 Trials Near Me

Home › Alzheimer's Disease › NCT00869817

Dominantly Inherited Alzheimer Network (DIAN)

RecruitingObservational studyHealthy volunteers welcome

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Written informed consent obtained from participant and collateral source prior to any study-related procedures.
* Aged 18 (inclusive) or older and the child of an affected individual (clinically or by testing) in a pedigree with a known mutation for ADAD.
* Cognitively normal to very mild or mild cognitive impairment (CDR score range 0-1.0). Primary enrollment will focus on the recruitment of asymptomatic adult children who are more than 15 years younger than the estimated age of symptom onset. Enrollment of new participants with moderate cognitive impairment is allowed with the prior approval of the DIAN Coordinating Center.
* Has two persons who are not their full-blooded siblings who can serve as collateral sources for the study.
* Fluent in a language approved by the DIAN Coordinating Center at about the 6th grade level (international equivalent) or above.

Exclusion Criteria:

* Under age 18
* Medical or psychiatric illness that would interfere in completing initial and follow-up visits
* Requires nursing home level care
* Has no one who can serve as a study informant

About the study

The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.

Sponsor: Washington University School of Medicine · Participants: 700 · Started: 2009-01

Contact the study team

Official record on ClinicalTrials.gov — NCT00869817

Locations in the U.S.

FloridaMayo Clinic Jacksonville, Jacksonville
IndianaIndiana University-Indiana Alzheimer Disease Center, Indianapolis
MassachusettsBrigham and Women's Hospital, Boston
MissouriWashington University in St. Louis School of Medicine, St Louis
PennsylvaniaUniversity of Pittsburgh, Pittsburgh
Rhode IslandButler Hospital, Providence
WashingtonUniversity of Washington, Seattle

Conditions

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.